Key Market Indicators
British vaccination coverage for children aged one is projected to remain stable at 93% by 2028, consistent with the 93% coverage observed in 2023. This stability comes despite a historical decline of 0.2 percentage points year-on-year since 1985. In the realm of vaccine exports, the United Kingdom is expected to see significant growth. By 2028, British vaccine exports are forecasted to reach approximately $6.4 billion, up from $5.4 billion in 2023. This represents an average annual growth rate of 2.7%. Since 1998, the UK's vaccine supply has increased at an average annual rate of 4.7%. In 2023, the UK ranked third globally in vaccine exports, trailing Belgium, which also recorded $5.4 billion in exports. Belgium, the United Kingdom, and France occupied the second, third, and fourth spots in the global ranking, respectively. On the import side, the UK's vaccine imports are set to rise to about $3 billion by 2028, up from $2.6 billion in 2023, reflecting an average annual growth rate of 2%. Since 1998, British demand for vaccines has increased by 3.6% annually.
